Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 18/20 | 0.62 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14498065 | 1.00 | KISS1R (0.62) | KISS1RIL23R | |
| SCHEMBL12417315 | 0.95 | KISS1R (0.65) | KISS1RIL23R | |
| SCHEMBL13248723 | 0.95 | KISS1R (0.65) | KISS1RIL23R | |
| SCHEMBL14498068 | 0.95 | KISS1R (0.65) | KISS1RIL23R | |
| SCHEMBL14498050 | 0.92 | IL23R (0.64) | KISS1RIL23R | |
| SCHEMBL12417309 | 0.92 | IL23R (0.64) | KISS1RIL23R | |
| SCHEMBL13248726 | 0.92 | KISS1R (0.66) | KISS1RIL23R | |
| SCHEMBL14498063 | 0.92 | IL23R (0.63) | KISS1RIL23R | |
| SCHEMBL29400465 | 0.91 | KISS1R (0.69) | KISS1RIL23R | |
| SCHEMBL12417304 | 0.90 | KISS1R (0.59) | KISS1RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070135351-A1 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | CONDE-KNAPE KARIN | 2007-06-14 | — | — | US | disclosed |
| US-20070135351-A1 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | CONDE-KNAPE KARIN | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135351-A1 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | NPY2R, NPY1R, NPY4R | KISS1R 131/4885IL23R 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.